SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 6.90% to Rs. 1856.40 millions for the quarter ended June 2024 as compared to Rs. 1736.60 millions during the corresponding quarter last year.The Net Profit of the company registered a slight decline of -4.89% to Rs. 725.40  millions from Rs. 762.70 millions.The company reported a degrowth in operating Profit to 1028.80 millions from 1038.90 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1856.40 1736.60 6.90 1856.40 1736.60 6.90 6250.90 5286.10 18.25
Other Income 215.00 272.70 -21.16 215.00 272.70 -21.16 1058.40 990.00 6.91
PBIDT 1028.80 1038.90 -0.97 1028.80 1038.90 -0.97 3929.20 3189.20 23.20
Interest 0.20 0.30 -33.33 0.20 0.30 -33.33 1.00 1.20 -16.67
PBDT 1028.60 1038.60 -0.96 1028.60 1038.60 -0.96 3928.20 3188.00 23.22
Depreciation 61.80 66.70 -7.35 61.80 66.70 -7.35 270.80 256.50 5.58
PBT 966.80 971.90 -0.52 966.80 971.90 -0.52 3657.40 2931.50 24.76
TAX 241.40 209.20 15.39 241.40 209.20 15.39 820.30 588.90 39.29
Deferred Tax -4.30 -9.80 -56.12 -4.30 -9.80 -56.12 -40.90 -76.90 -46.81
PAT 725.40 762.70 -4.89 725.40 762.70 -4.89 2837.10 2342.60 21.11
Equity 152.00 151.90 0.07 152.00 151.90 0.07 151.90 151.80 0.07
PBIDTM(%) 55.42 59.82 -7.36 55.42 59.82 -7.36 62.86 60.33 4.19

Caplin Point Lab Share Price

1772.50 6.05 (0.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×